Your browser doesn't support javascript.
loading
Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis.
Denton, Christopher P; Del Galdo, Francesco; Khanna, Dinesh; Vonk, Madelon C; Chung, Lorinda; Johnson, Sindhu R; Varga, John; Furst, Daniel E; Temple, Jane; Zecchin, Chiara; Csomor, Eszter; Lee, Amy; Wisniacki, Nicolas; Flint, Shaun M; Reid, Juliet.
Afiliação
  • Denton CP; Centre for Rheumatology and Connective Tissue Diseases, Division of Medicine, University College London, London.
  • Del Galdo F; Institute of Rheumatic and Musculoskeletal Medicine, and Biomedical Research Centre, University of Leeds, Leeds, UK.
  • Khanna D; Scleroderma Program, University of Michigan, Ann Arbor, MI, USA.
  • Vonk MC; Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Chung L; Stanford University School of Medicine and Palo Alto VA Health Care System, Palo Alto, CA, USA.
  • Johnson SR; Toronto Scleroderma Program, Toronto Western Hospital.
  • Varga J; Mount Sinai Hospital, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
  • Furst DE; Scleroderma Program, University of Michigan, Ann Arbor, MI, USA.
  • Temple J; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL.
  • Zecchin C; University of California, Los Angeles, Los Angeles, CA.
  • Csomor E; University of Washington, Seattle, WA, USA.
  • Lee A; University of Florence, Florence, Italy.
  • Wisniacki N; GlaxoSmithKline, Uxbridge.
  • Flint SM; GlaxoSmithKline, Stevenage, UK.
  • Reid J; GlaxoSmithKline, Stevenage, UK.
Rheumatology (Oxford) ; 62(1): 234-242, 2022 12 23.
Article em En | MEDLINE | ID: mdl-35583273

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article